OCEA: מחיר למכירות Ocean Bio

Ocean Biomedical, Inc. (OCEA) is developing a closed patent loop to combat malaria and cancer. This chart on GURU.Markets shows that the price-to-sales ratio has reached the metric. The business model relies on the commercialization of university research and the production of vaccines. However, a lack of internal revenue and the depletion of reserves force the company to regularly seek third-party investment.

Analyzing the scale of Ocean Biomedical, Inc. (OCEA) through changes in the price-to-sales ratio allows for a comparison of the business's market value with actual sales volume. This metric links market capitalization to revenue and debt load, revealing asset overheating or liquidity risks, which is critical for biopharmaceuticals amid sanction threats to raw material supply chains and the complexities of foreign patent protection.